Komori
Nihon Trim (6788) · RiskMitigated

Impact of the Market-Wide Consumption Slump on Water Ionizer Sales

First written in FY2020-Q3. 4 of 8 entries say "Mitigated", first in FY2021-Q2. Latest entry: FY2023-Q3.

8entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2020-Q3 – FY2020MitigatedFY2021-Q2 – FY2021-Q32020: 420202021: 120212022: 220222023: 12023
Same theme, other companies
Economic slowdown and decline in customer demand due to COVID-19A theme 193 companies write about · 193 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 112 of 175 companies on the "Worse" side.

56 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 193 companies compared. The sentences above are computed from all 193.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3MitigatedAnnual report

    「The number of COVID-19 cases has been declining from its peak at the beginning of this year, and it has also been decided that COVID-19 will be reclassified under Category 5 of the Infectious Diseases Act in May this year. Face-to-face sales are finally moving toward normalization.」

    Regarding the impact of the COVID-19 pandemic on the market and sales activities, the Company explained that face-to-face sales are moving toward normalization against a backdrop of declining infections and the decision to reclassify COVID-19 as a Category 5 disease.
  2. FY2023-Q2MitigatedAnnual report

    「Although the direct-sales division of the water ionizer sales business continues to feel some aftereffects of the COVID-19 pandemic, the sales environment has improved overall, and we will work to move from recovery to growth.」

    Although the aftereffects of the COVID-19 pandemic remain, the sales environment in the direct-sales division has improved overall, and the Company aims to move from recovery to growth.
  3. FY2023-Q1WorsenedAnnual report

    「COVID-19 infections have been spreading rapidly since July, causing some impact on the water ionizer sales business, but we have been able to conduct more extensive sales activities than in the previous fiscal year.」

    While face-to-face sales were recovering, water ionizer sales were affected to some extent by the rapid increase in infections in July, indicating that infectious-disease risk has re-emerged.
  4. FY2021-Q3MitigatedAnnual report

    「The recovery of the direct sales divisions through stronger expansion to local small and midsize companies, together with growth in the wholesale division, helped water ionizer revenue turn positive, rising 8.5% year on year in the third-quarter consolidated accounting period.」

    Despite continued restrictions on face-to-face sales due to the COVID-19 pandemic, water ionizer sales in the third-quarter accounting period recovered to year-on-year growth, driven by stronger expansion among local small and medium-sized companies and growth in the wholesale division.
  5. FY2021-Q2MitigatedAnnual report

    「In April and May, under the state of emergency, the number of workplace-sales seminars fell to approximately 20% of the year-earlier level. However, efforts to expand operations, particularly among leading local small and medium-sized companies, through the health-management proposals described above proved effective, and the level has now almost returned to that before the COVID-19 pandemic.」

    Although the state of emergency reduced the number of seminars to approximately 20% of the year-earlier level, sales activities have almost recovered to pre-pandemic levels through health-management proposals and other initiatives.
  6. FY2021-Q1RestatedAnnual report

    「In the water ionizer sales business, the number of workplace-sales seminars in April and May fell to approximately 20% of the year-earlier levels due to the impact of the COVID-19 pandemic. However, revenue was secured through initiatives including a replacement campaign for existing users and steady growth in sales of water-purification cartridges, a recurring-revenue business.」

    While the number of workplace-sales seminars in April and May fell to approximately 20% of the year-earlier levels due to the COVID-19 pandemic, revenue was secured through replacement campaigns and cartridge sales.
  7. FY2020WorsenedAnnual report

    「Water ionizer sales were on track with the initial plan through the third quarter despite the cooling of overall consumer spending caused by the consumption tax increase, but were affected to some extent in the fourth quarter by the COVID-19 pandemic. In March in particular, based on estimates calculated from the postponement and cancellation of scheduled seminars, exhibitions and other events, we believe that water ionizer sales decreased by at least ¥370 million due to the pandemic.」

    In addition to the risk of weak overall consumer spending, seminars and exhibitions were postponed or cancelled because of the COVID-19 pandemic, and water ionizer sales in March were stated to have decreased by at least ¥370 million.
  8. FY2020-Q3MaterialisedAnnual report

    「Despite this environment, corporate sales focused on the Company's Health Management® offering have begun to see cases in which companies subsidize purchases for employees as part of their employee benefits, in addition to bulk installations by companies, indicating further scope for expansion.」

    While affected by the decline in overall consumer spending, the Company's corporate health-management sales saw an expansion in adoption cases.
Moved together

"Expansion of Overseas Sales Channels and Production Facilities, Centered on Indonesia" moved the same way as this thread, in the same document, in 4 of its 8 moves.

444444★123456
  1. ★This thread
  2. 1Expansion of Overseas Sales Channels and Production Facilities, Centered on Indonesia4×
  3. 2Improving Water Purifier Cartridge Replacement Rates4×
  4. 3Storage, research and provision to medical institutions of cord blood-derived stem cells4×
  5. 4Expansion of cord blood bank storage capacity4×
  6. 5Expansion of Large-Scale OEM Projects and New Business4×
  7. 6Uncertainty over the Earnings Impact of the Chinese Hospital Operating Business4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nihon Trim yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.